In patients with heart failure, does the implantable cardioverter-defibrillator prolong survival?;Nei pazienti con insufficienza cardiaca il cardioverter-defibrillatore impiantabile ritarda la morte o salva la vita?

Italian Heart Journal Supplement

Volumn 3, Issue 1, 2002, Pages 36-44

  Berisso, Massimo Zoni ^a   Delfino, Luigi ^a   Viani, Stefano ^a  

^a GALLIERA HOSPITAL   (Italy)

Author keywords

Heart failure; Implantable cardioverter defibrillator; Left ventricular dysfunction; Sudden cardiac death

Indexed keywords

CARDIOVERSION; CAUSE OF DEATH; CORONARY RISK; DEFIBRILLATION; DEFIBRILLATOR; DEVICE; DISEASE SEVERITY; HEART DEATH; HEART FAILURE; HEART VENTRICLE ARRHYTHMIA; HOSPITALIZATION; HUMAN; IMPLANTATION; INCIDENCE; MORBIDITY; MORTALITY; REVIEW; SUDDEN DEATH; SURVIVAL;

DEATH, SUDDEN; DEFIBRILLATORS, IMPLANTABLE; FORECASTING; HEART FAILURE, CONGESTIVE; HUMANS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TIME FACTORS;

EID: 0036206731     PISSN: 11294728     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. Medical advances in the treatment of congestive heart failure
2. Clinical effects of beta-adrenergic blockade in chronic heart failure: A meta-analysis of double-blind, placebo-controlled, randomized trials
3. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: Meta-analysis of individual data from 6500 patients in randomised trials
4. The effect of spironolactone on morbidity and mortality in patients with severe heart failure
5. Estimating clinical morbidity due to ischemic heart disease and congestive heart failure: The future rise of heart failure
6. Short and long term prognosis of acute myocardial infarction since introduction of thrombolysis
7. The epidemiology of heart failure
8. Studio sulla epidemiologia e sull'assorbimento di risorse di ischemia, scompenso e aritmie
9. Survey on heart failure in Italian hospital cardiology units. Results of the SEOSI study
10. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
11. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
12. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial
13. Randomised trial of low-dose amiodarone in severe congestive heart failure
14. Actuarial risk of sudden death while awaiting cardiac transplantation in patients with atherosclerotic heart disease
15. Clinical classification of cardiac deaths
16. Classification of deaths after myocardial infarction as arrhythmic or nonarrhythmic (The Cardiac Arrhythmia Pilot study)
17. Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death
18. Mechanism of death in heart failure. The Vasodilator-Heart Failure trials
19. Arrhythmias and mortality in congestive heart failure
20. Mortality and morbidity in patients receiving encainide, flecainide or placebo. The Cardiac Arrhythmia Suppression trial
21. Quinidine-related mortality in the short-to-medium-term treatment of ventricular arrhythmias. A meta-analysis
22. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation
23. Proarrhythmic effects of antiarrhythmic drugs
24. A randomized study of the prevention of sudden death in patients with coronary artery disease
25. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest. The Cardiac Arrest Study Hamburg (CASH)
26. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy
27. Idiopathic ventricular fibrillation: From a collection of clinical cases to a prospective evaluation
28. Implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular cardiomyopathy, long QT syndrome, or no structural heart disease
29. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias
30. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia
31. Canadian Implantable Defibrillator Study: A randomized trial of the implantable cardioverter defibrillator against amiodarone
32. Impact of the implantable defibrillator on mortality: The axiom of overall implantable cardioverter-defibrillator survival
33. Cardiac arrest and sudden cardiac death in heart disease
34. Exploration of the precision of classifying sudden cardiac death. Implications for the interpretation of clinical trials
35. Ambulatory sudden cardiac death: Mechanisms of production of fatal arrhythmia on the basis of data of 157 cases
36. Sudden death during continuous Holter monitoring out of hospital after nitroglycerin assumption
37. Sudden death during long-term ambulatory monitoring
38. Survivors of prehospital cardiac arrest
39. Prehospital defibrillation performed by emergency medical technicians in rural communities
40. Mechanism of death and prevalence of myocardial ischemic symptoms in the terminal event after acute myocardial infarction
41. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure
42. Cardiac arrest recorded on ambulatory electrocardiograms
43. Sudden death in implantable cardioverter-defibrillator recipients: Clinical context, arrhythmic events and device responses
44. When "sudden cardiac death" is not so sudden: Lesson from the automatic implantable defibrillator
45. Sudden unexpected death in patients with congestive heart failure: A second frontier
46. Lack of relation between ventricular arrhythmias and sudden death in patients with chronic heart failure
47. The impact of left ventricular dysfunction on outcomes with the implantable defibrillator
48. Cardiac arrest and resuscitation: A tale of 29 cities
49. Results of the international study of the implantable pacemaker cardioverter-defibrillator: A comparison of epicardial and endocardial lead system
50. Non-thoracotomy defibrillator systems: Who is a candidate?
51. Comparison of outcome of implantable cardioverter-defibrillator implantation in patients with severe versus moderately severe left ventricular dysfunction secondary to atherosclerotic coronary artery disease
52. Safety of antitachycardia pacing in patients with implantable cardioverter-defibrillators and severely depressed ventricular function
53. Electrical storm in patients with transvenous implantable cardioverter-defibrillator. Incidence, management and prognostic implications
54. Sudden death with implantable cardioverter-defibrillators
55. Relation between shock-related myocardial injury and defibrillation efficacy of monophasic and biphasic shocks in a canine model
56. Incidence and clinical significance of multiple consecutive, appropriate, high-energy discharges in patients with implanted cardioverter-defibrillators
57. Long-term follow-up of patients with implantable cardioverter-defibrillators and mild, moderate, or severe impairment of left ventricular function
58. Device use patterns and clinical outcome of implantable cardioverter-defibrillator in patients with moderate and severe impairment of left ventricular function
59. Potential benefit from implantable cardioverter-defibrillator in patients with and without heart failure
60. Influence of the implantable cardioverter-defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation
61. The impact of implantable cardioverter-defibrillators on mortality among patients on the waiting list for heart transplantation
62. Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias
63. Implantable cardioverter-defibrillator therapy: The sickest patients benefit the most
64. Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy. The Canadian Implantable Defibrillator Study
65. Stratificazione e prevenzione del rischio aritmico nella cardiopatia dilatativa non ischemica
66. Individuazione dei soggetti a rischio di morte aritmica nell'insufficienza cardiaca avanzata
67. Sudden cardiac death
68. The Sudden Cardiac Death in Heart Failure trial: A pilot study
69. Multicenter Automatic Defibrillator Implantation Trial II (MADIT II): Design and clinical protocol
70. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HeFT and MADIT-II
71. Primary prevention of sudden cardiac death in heart failure: Will the solution be shocking?